Ligan, Baby Boy .
HRN: 24-32-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/29/2024
03/06/2024
IVT
30mg
Q24
Prophylaxis; Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes